JAMA Netw Open 7(8):e2423385 Zhou J, Huang W, Xie Y, Shen H, Liu M, Wu X (2025) Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
We'll refund you everything, right
Less common reports include fatigue 1224 hours after dosing, injection-site redness, and brief flushing
Compounded semaglutide and tirzepatide are manufactured by compounding pharmacies rather than the original drug manufacturers
The biggest thing I see is drinking alcohol
Semaglutide is primarily recognized for its metabolic benefits, including regulating blood glucose levels, promoting weight loss, and enhancing lipid profiles